Literature DB >> 10505008

The repositioning of migrated Tenckhoff continuous ambulatory peritoneal dialysis catheters under fluoroscopic control.

R D Dobrashian1, B Conway, A Hutchison, R Gokal, P M Taylor.   

Abstract

We describe a non-invasive, simple technique which, under fluoroscopic control, repositions migrated Tenckhoff CAPD catheters back into the pelvis. 18 patients, who had a total of 23 manipulations, were studied retrospectively over 2 1/2 years. Technical success (successful repositioning of the catheter at screening) and clinical success (continued effective CAPD for at least 6 months thereafter) were obtained in 84% and 45% of patients respectively. The results showed this technique to be effective in restoring the correct catheter position in CAPD patients whose catheters have migrated. Clinical success was more likely to be achieved in patients who had fewer risk factors for the development of peritoneal adhesions. The use of custom-made stainless steel wires eased manipulations and significantly reduced the radiation dose to patient and operator from the procedure.

Entities:  

Mesh:

Year:  1999        PMID: 10505008     DOI: 10.1259/bjr.72.857.10505008

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  3 in total

1.  Spontaneous cure of migrated peritoneal catheter.

Authors:  Yanala Sandeep Reddy; Yadla Manjusha; Chennu Krishna Kishore; Nagasri Sridhar; Parvathina Sriramnaveen; Vishnubhotla Sivakumar
Journal:  Perit Dial Int       Date:  2012 Jan-Feb       Impact factor: 1.756

2.  Guidelines for laparoscopic peritoneal dialysis access surgery.

Authors:  Stephen Haggerty; Scott Roth; Danielle Walsh; Dimitrios Stefanidis; Raymond Price; Robert D Fanelli; Todd Penner; William Richardson
Journal:  Surg Endosc       Date:  2014-10-08       Impact factor: 4.584

3.  Efficacy and safety of fluoroscopic manipulation using the alpha-replacer for peritoneal catheter malposition.

Authors:  Yosuke Saka; Yasuhiko Ito; Yoshiyasu Iida; Shoichi Maruyama; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2014-07-17       Impact factor: 2.801

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.